Free Trial
OTCMKTS:CAPS

Capstone (CAPS) Stock Price, News & Analysis

Capstone logo
$2.40 -0.10 (-4.00%)
As of 03/28/2025 04:00 PM Eastern

About Capstone Stock (OTCMKTS:CAPS)

Key Stats

Today's Range
$2.36
$2.60
50-Day Range
$1.72
$3.90
52-Week Range
$1.72
$16.18
Volume
16,105 shs
Average Volume
819,846 shs
Market Capitalization
$379,200.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.

Remove Ads
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Capstone Wellness Addiction Treatment
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Capstone Companies signs MOU to initiate strategic collaboration
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone's stock was trading at $2.24 at the beginning of 2025. Since then, CAPS shares have increased by 7.1% and is now trading at $2.40.
View the best growth stocks for 2025 here
.

Capstone Holding Corp. (OTCMKTS:CAPS) posted its quarterly earnings results on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company earned $2 million during the quarter.

Capstone's quiet period expires on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During Capstone's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Capstone investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
8/13/2018
Today
3/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CAPS
Employees
38
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$44.05 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
90,000
Market Cap
$379,200.00
Optionable
Not Optionable
Beta
-0.85

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:CAPS) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners